Complement component C5a activates ICAM-1 expression on human choroidal endothelial cells
about
Complement activation in the context of stem cells and tissue repairIntravenous ascorbic acid as an adjuvant to interleukin-2 immunotherapyAnaphylatoxins Activate Ca2+, Akt/PI3-Kinase, and FOXO1/FoxP3 in the Retinal Pigment EpitheliumMarkers of inflammation, oxidative stress, and endothelial dysfunction and the 20-year cumulative incidence of early age-related macular degeneration: the Beaver Dam Eye Study.Complement-Mediated Enhancement of Monocyte Adhesion to Endothelial Cells by HLA Antibodies, and Blockade by a Specific Inhibitor of the Classical Complement Cascade, TNT003Cadherin 5 is regulated by corticosteroids and associated with central serous chorioretinopathyChoriocapillaris vascular dropout related to density of drusen in human eyes with early age-related macular degenerationAurintricarboxylic acid inhibits complement activation, membrane attack complex, and choroidal neovascularization in a model of macular degeneration.Complement activation and choriocapillaris loss in early AMD: implications for pathophysiology and therapy.The interaction between circulating complement proteins and cutaneous microvascular endothelial cells in the development of childhood Henoch-Schönlein Purpura.Complement Factor H Expressed by Retinal Pigment Epithelium Cells Can Suppress Neovascularization of Human Umbilical Vein Endothelial Cells: An in vitro Study.Regulation of age-related macular degeneration-like pathology by complement factor H.Inflammatory Mechanisms of Age-related Macular Degeneration.Effects of antioxidant components of AREDS vitamins and zinc ions on endothelial cell activation: implications for macular degenerationAn integrative genome-wide transcriptome reveals that candesartan is neuroprotective and a candidate therapeutic for Alzheimer's diseaseConnecting the innate and adaptive immune responses in mouse choroidal neovascularization via the anaphylatoxin C5a and γδT-cells.Anti-complement component 5 antibody targeting MG4 domain inhibits choroidal neovascularization.Higher plasma levels of complement C3a, C4a and C5a increase the risk of subretinal fibrosis in neovascular age-related macular degeneration: Complement activation in AMD.Proteomic analysis of vitreous biopsy techniquesPrevalence of Subretinal Drusenoid Deposits in Older Persons with and without Age-Related Macular Degeneration, by Multimodal Imaging.Molecular response of chorioretinal endothelial cells to complement injury: implications for macular degeneration.CFH Y402H polymorphism and the complement activation product C5a: effects on NF-κB activation and inflammasome gene regulationLoss of CD34 expression in aging human choriocapillaris endothelial cells.Autosomal recessive retinitis pigmentosa due to ABCA4 mutations: clinical, pathologic, and molecular characterization.Current Clinical Trials in Dry AMD and the Definition of Appropriate Clinical Outcome Measures.Targeted complement inhibition and microvasculature in transplants: a therapeutic perspective.Complement Component C5a Primes Retinal Pigment Epithelial Cells for Inflammasome Activation by Lipofuscin-mediated Photooxidative DamageElevated membrane attack complex in human choroid with high risk complement factor H genotypes.Selective accumulation of the complement membrane attack complex in aging choriocapillaris.Structural and molecular changes in the aging choroid: implications for age-related macular degeneration.Endothelial cells: source, barrier, and target of defensive mediators.Modulation of retinal Müller cells by complement receptor C5aR.From compliment to insult: genetics of the complement system in physiology and disease in the human retina.Monomeric C-reactive protein and inflammation in age-related macular degeneration.Neuroinflammation induced by intracerebroventricular injection of microbial neuraminidase.Complement factor H in AMD: Bridging genetic associations and pathobiology.Matrix stiffness exerts biphasic control over monocyte-endothelial adhesion via Rho-mediated ICAM-1 clustering.Bruch's Membrane Compartmentalizes Complement Regulation in the Eye with Implications for Therapeutic Design in Age-Related Macular Degeneration.Bruch’s Membrane Compartmentalizes Complement Regulation in the Eye with Implications for Therapeutic Design in Age-Related Macular Degeneration.Complement Receptor C5aR1 Plays an Evolutionarily Conserved Role in Successful Cardiac Regeneration.
P2860
Q26782203-1C2BB11B-19E5-4124-A205-1510E47B0E7EQ27027097-CA997C43-F8F6-4226-802E-847697B9051BQ33802700-DA7150A3-DBC9-4DAF-A536-755E3E7DF214Q33824902-570DA2E7-652F-4B49-B7BA-270D1F1E8818Q33829159-692F6454-8E41-455C-BD40-D7CD710FBC14Q34434358-155B21AD-9879-4686-A505-AF4B72C3B725Q35005946-8D756FCD-5863-4104-A3F3-645700355A42Q35012333-B6B3EB50-5BD4-4771-B0F2-C294C7D84CCBQ35118257-F2DCD754-17F7-4BB0-87E0-85885D3ACD3AQ35168168-2F4D1560-FEBB-4B28-9050-CEB939513647Q35668873-C9F2005F-A981-424D-8542-9E9789C5B160Q35740328-ED19C19A-1BA9-463B-AC5F-4A07C2118B24Q35755942-AD69693F-A15D-48E8-AED3-819C6D69BB89Q35865378-C3039FE9-9EBF-4D62-B9B4-614894D6D705Q35907609-5DF348ED-33C7-4BA2-8D07-94594146F75EQ35974464-C1677002-9EB6-4EDB-8E39-17F371AC8523Q36364687-81A1149C-3398-43F0-9930-530F7439DD93Q36583714-21D4E063-1CB4-43B5-A874-555D2E23A4C6Q36797319-02A60F29-55D2-4D56-9E09-353DD1805F91Q36828388-A31452B6-E072-4292-ADBD-AA0BEC155CCAQ36987345-DE397C35-10DF-4693-BA86-B9B809634A3DQ37088454-F91E58D0-95B9-46AE-9206-58D263470311Q37500428-6D4F8BC3-9B55-4E8A-89DB-501AAB3F83D0Q37716568-1C50F7D8-9F90-4B59-9D4E-4BE1A8AE381DQ37879172-7EB728A0-64E7-483F-B9D7-7E4D9140240AQ38592520-7E5D05ED-88AF-49E2-BDF1-80AA33371D35Q38819720-23C2CD03-DD0B-4748-A657-0FDFBBF5EEDCQ38906290-46C16E57-3B3C-4697-BFFE-662EF7746EACQ38948255-9CB973BC-B1E1-4F2D-8BD1-6C6A7447943EQ38975097-6B68421D-56BB-4E40-AC25-C3E6094F11DFQ38991026-5ED72F1A-4061-4830-99A4-1FCD6A10F2AAQ39058653-C596DCDD-1284-4A7E-BC37-0D7EC1369D36Q39290950-C7555CE7-B4F8-41CB-BD7B-C8BEDEB26CD8Q39633569-99ECD7CB-6A64-4F08-AD28-4509AAE4A07FQ43189337-861EB593-6BA8-4ED3-9C83-C7BED943F143Q46022690-06869149-D3A2-4B4D-81A3-372A1EAEF36FQ46177164-2EDCF367-9A3E-4872-834C-4A6434244B04Q47221253-A1392A1D-52C9-4B11-904E-BC87EF88FFC1Q47232126-CFE2B92E-612E-4E57-99E9-51F9F82D32E1Q47653397-96C6EBD6-8DE4-4092-A2DF-3CF8AAD0AE78
P2860
Complement component C5a activates ICAM-1 expression on human choroidal endothelial cells
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Complement component C5a activates ICAM-1 expression on human choroidal endothelial cells
@ast
Complement component C5a activates ICAM-1 expression on human choroidal endothelial cells
@en
Complement component C5a activates ICAM-1 expression on human choroidal endothelial cells
@nl
type
label
Complement component C5a activates ICAM-1 expression on human choroidal endothelial cells
@ast
Complement component C5a activates ICAM-1 expression on human choroidal endothelial cells
@en
Complement component C5a activates ICAM-1 expression on human choroidal endothelial cells
@nl
prefLabel
Complement component C5a activates ICAM-1 expression on human choroidal endothelial cells
@ast
Complement component C5a activates ICAM-1 expression on human choroidal endothelial cells
@en
Complement component C5a activates ICAM-1 expression on human choroidal endothelial cells
@nl
P2860
P50
P356
P1476
Complement component C5a activates ICAM-1 expression on human choroidal endothelial cells
@en
P2093
Jessica M Skeie
P2860
P304
P356
10.1167/IOVS.10-5322
P407
P577
2010-05-19T00:00:00Z